Promising clinical data surrounding the medication Retatrutide , specifically the 120 milligram formulation ZPHC ZPHC, reveal a considerable impact on weight reduction and associated metabolic illnesses . Scientists posit that this innovative compound, affecting both GLP-1 and GIP systems, could